Hubei Goto Biopharm Co.,Ltd. (SHE:300966)

China flag China · Delayed Price · Currency is CNY
17.12
+0.37 (2.21%)
May 16, 2025, 3:04 PM CST
-16.89%
Market Cap 1.97B
Revenue (ttm) 553.58M
Net Income (ttm) -30.06M
Shares Out 115.28M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend 0.02 (0.10%)
Ex-Dividend Date n/a
Volume 2,957,700
Average Volume 2,111,919
Open 16.66
Previous Close 16.75
Day's Range 16.50 - 17.23
52-Week Range 13.04 - 23.50
Beta 0.12
RSI 61.26
Earnings Date Apr 24, 2025

About Hubei Goto Biopharm

Hubei Goto Biopharm Co.,Ltd. engages in the research, development, production, and sale of steroid drug raw materials and intermediates in China and internationally. It offers starting materials, such as androstenedione, bisnordiol, and 9-hydroxyandrostenedione; intermediates, including sex hormone, progesterone, corticosteroid, and other pharmaceutical raw materials. The company was founded in 2006 and is based in Xiangyang, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 631
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300966
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.